193
Views
0
CrossRef citations to date
0
Altmetric
Articles

Relations between clinical characteristics and cognitive deficits among adult patients diagnosed with major depressive disorder

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 219-231 | Received 19 Jan 2022, Accepted 08 Nov 2022, Published online: 30 Nov 2022

References

  • Ashendorf, L., Jefferson, A. L., O'Connor, M. K., Chaisson, C., Green, R. C., & Stern, R. A. (2008). Trail Making Test errors in normal aging, mild cognitive impairment, and dementia. Archives of Clinical Neuropsychology, 23(2), 129–137. doi:10.1016/j.acn.2007.11.005
  • Airaksinen, E., Wahlin, Å., Forsell, Y., & Larsson, M. (2007). Low episodic memory performance as a premorbid marker of depression: Evidence from a 3‐year follow‐up. Acta Psychiatrica Scandinavica, 115(6), 458–465. doi:10.1111/j.1600-0447.2006.00932.x
  • Ambaw, A., & Desalegn, G. T. (2019). Magnitude and correlates of cognitive impairment among major depressive disorder patients in Addis Ababa: Institution based cross-sectional study. BMC Research Notes, 12(1), 135. doi:10.1186/s13104-019-4184-5
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. DSM-5 (5th ed.). American Psychiatric Publishing.
  • Andrea, S., Xénia, G., Gabriella, B., Anna, S, Mária, S., & Gábor, F. (2008). A depresszió neurokognitív összetevo inek és nemi különbségeinek vizsgálata. Neuropsychopharmacologia Hungarica, 10(4), 191–199.
  • Austin, M. P., Mitchell, P., & Goodwin, G. M. (2001). Cognitive deficits in depression: Possible implications for functional neuropathology. The British Journal of Psychiatry, 178, 200–206. doi:10.1192/bjp.178.3.200
  • Austin, M. P., Ross, M., Murray, C., O'Carroll, R. E., Ebmeier, K. P., & Goodwin, G. M. (1992). Cognitive function in major depression. Journal of Affective Disorders, 25(1), 21–29. doi:10.1016/0165-0327(92)90089-O
  • Bang-Andersen, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., Zhong, H., Nielsen, S. M., Hogg, S., Mørk, A., & Stensbøl, T. B. (2011). Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl] piperazine (Lu AA21004): A novel multimodal compound for the treatment of major depressive disorder. Journal of Medicinal Chemistry, 54(9), 3206–3221. doi:10.1021/jm101459g
  • Baune, B. T., Czira, M. E., Smith, A. L., Mitchell, D., & Sinnamon, G. (2012). Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder. Journal of Affective Disorders, 141(2–3), 441–448. doi:10.1016/j.jad.2012.02.041
  • Baune, B. T., Fuhr, M., Air, T., & Hering, C. (2014). Neuropsychological functioning in adolescents and young adults with major depressive disorder–A review. Psychiatry Research, 218(3), 261–271. doi:10.1016/j.psychres.2014.04.052
  • Beblo, T., Sinnamon, G., & Baune, B. T. (2011). Specifying the neuropsychology of affective disorders: Clinical, demographic and neurobiological factors. Neuropsychology Review, 21(4), 337–359. doi:10.1007/s11065-011-9171-0
  • Bora, E., Harrison, B. J., Yücel, M., & Pantelis, C. (2013). Cognitive impairment in euthymic major depressive disorder: A meta-analysis. Psychological Medicine, 43(10), 2017–2026. doi:10.1017/S0033291712002085
  • Bortolato, B. F., Carvalho, A. S., & McIntyre, R. (2014). Cognitive dysfunction in major depressive disorder: A state-of-the-art clinical review. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 13(10), 1804–1818.
  • Brenner, M. H., Curbow, B., & Legro, M. W. (1995). The proximal-distal continuum of multiple health outcome measures: The case of cataract surgery. Medical Care, 33(4 Suppl), AS236–AS244.
  • Castaneda, A. E., Suvisaari, J., Marttunen, M., Perälä, J., Saarni, S. I., Aalto-Setälä, T., Aro, H., Koskinen, S., Lönnqvist, J., & Tuulio-Henriksson, A. (2008). Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. Journal of Affective Disorders, 110(1–2), 36–45. doi:10.1016/j.jad.2007.12.239
  • Cataldo, M. G., Nobile, M., Lorusso, M. L., Battaglia, M., & Molteni, M. (2005). Impulsivity in depressed children and adolescents: A comparison between behavioral and neuropsychological data. Psychiatry Research, 136(2-3), 123–133. doi:10.1016/j.psychres.2004.12.012
  • Chee, K.-Y., Tripathi, A., Avasthi, A., Chong, M.-Y., Xiang, Y.-T., Sim, K., Si, T.-M., Kanba, S., He, Y.-L., Lee, M.-S., Fung-Kum Chiu, H., Yang, S.-Y., Kuga, H., Udormatn, P., Kallivayalil, R. A., Tanra, A. J., Maramis, M., Grover, S., Chin, L.-F., … Sartorius, N. (2015). Country variations in depressive symptoms profile in Asian countries: Findings of the Research on Asia Psychotropic Prescription (REAP) studies. Asia-Pacific Psychiatry, 7(3), 276–285. doi:10.1111/appy.12170
  • Clark, M., DiBenedetti, D., & Perez, V. (2016). Cognitive dysfunction and work productivity in major depressive disorder. Expert Review of Pharmacoeconomics & Outcomes Research, 16(4), 455–463. doi:10.1080/14737167.2016.1195688
  • Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied multiple regression/correlation analysis for the behavioural sciences (3rd ed.). Lawrence Erlbaum Associates.
  • Coleman, K., Austin, B. T., Brach, C., & Wagner, E. H. (2009). Evidence on the chronic care model in the new millennium. Health Affairs (Project Hope), 28(1), 75–85. doi:10.1377/hlthaff.28.1.75
  • Conradi, H. J., Ormel, J., & De Jonge, P. (2011). Presence of individual (residual) symptoms during depressive episodes and periods of remission: A 3-year prospective study. Psychological Medicine, 41(6), 1165–1174. doi:10.1017/S0033291710001911
  • Dale, E., Zhang, H., Leiser, S. C., Xiao, Y., Lu, D., Yang, C. R., Plath, N., & Sanchez, C. (2014). Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. Journal of Psychopharmacology, 28(10), 891–902. doi:10.1177/0269881114543719
  • Daniel, B. D., Montali, A., Gerra, M. L., Innamorati, M., Girardi, P., Pompili, M., & Amore, M. (2013). Cognitive impairment and its associations with the path of illness in affective disorders: A comparison between patients with bipolar and unipolar depression in remission. Journal of Psychiatric Practice, 19(4), 275–287. doi:10.1097/01.pra.0000432597.79019.e2
  • Darcet, F., Gardier, A. M., Gaillard, R., David, D. J., & Guilloux, J. P. (2016). Cognitive dysfunction in major depressive disorder. A translational review in animal models of the disease. Pharmaceuticals, 9(1), 9. doi:10.3390/ph9010009
  • Department of Statistics Malaysia. (2016). Labour force survey report, Malaysia, 2017 April 28. https://www.dosm.gov.my/v1/index.php?r=column/pdfPrev&id=SGZCNnMrWW9ZTEdpYys4YW0yRlhoQT09.
  • Douglas, K. M., Gallagher, P., Robinson, L. J., Carter, J. D., McIntosh, V. V., Frampton, C. M., Watson, S., Young, A. H., Ferrier, I. N., & Porter, R. J. (2018). Prevalence of cognitive impairment in major depression and bipolar disorder. Bipolar Disorders, 20(3), 260–274. doi:10.1111/bdi.12602
  • Elgamal, S., Denburg, S., Marriott, M., & MacQueen, G. (2010). Clinical factors that predict cognitive function in patients with major depression. Canadian Journal of Psychiatry. Revue canadienne de psychiatrie, 55(10), 653–661. doi:10.1177/070674371005501004
  • Elgamal, S., McKinnon, M. C., Ramakrishnan, K., Joffe, R. T., & MacQueen, G. (2007). Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: A proof of principle study. Psychological Medicine, 37(9), 1229–1238. doi:10.1017/S0033291707001110
  • Fava, M., Graves, L. M., Benazzi, F., Scalia, M. J., Iosifescu, D. V., Alpert, J. E., & Papakostas, G. I. (2006). A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. The Journal of Clinical Psychiatry, 67(11), 1754–1759. doi:10.4088/jcp.v67n1113
  • Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008). A meta‐analytic study of changes in brain activation in depression. Human Brain Mapping, 29(6), 683–695. doi:10.1002/hbm.20426
  • Friedrich, M. J. (2017). Depression is the leading cause of disability around the world. JAMA, 317(15), 1517. doi:10.1001/jama.2017.3826
  • Gildengers, A. G., Butters, M. A., Chisholm, D., Anderson, S. J., Begley, A., Holm, M., Rogers, J. C., Reynolds, C. F., & Mulsant, B. H. (2012). Cognition in older adults with bipolar disorder versus major depressive disorder. Bipolar Disorders, 14(2), 198–205. doi:10.1111/j.1399-5618.2012.00995.x
  • Gilmour, H., & Patten, S. B. (2007). Depression and work impairment. Health Report, 18, 9–22.
  • Gorwood, P., Corruble, E., Falissard, B., & Goodwin, G. M. (2008). Toxic effects of depression on brain function: Impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. The American Journal of Psychiatry, 165(6), 731–739. doi:10.1176/appi.ajp.2008.07040574
  • Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015). Economic burden of adults with major depressive disorder in the United States (2005 and 2010). The Journal of Clinical Psychiatry, 76(2), 155–162. doi:10.4088/JCP.14m09298
  • Gualtieri, C. T., & Morgan, D. W. (2008). The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: An unaccounted source of variance in clinical trials. The Journal of Clinical Psychiatry, 69(7), 1122–1130. doi:10.4088/jcp.v69n0712
  • Gualtieri, C. T., Johnson, L. G., & Benedict, K. B. (2006). Neurocognition in depression: Patients on and off medication versus healthy comparison subjects. The Journal of Neuropsychiatry and Clinical Neurosciences, 18(2), 217–225. doi:10.1176/jnp.2006.18.2.217
  • Hammar, Å., & Årdal, G. (2009). Cognitive functioning in major depression-a summary. Frontiers in Human Neuroscience, 3, 26. doi:10.3389/neuro.09.026.2009
  • Harrison, J. E., Lophaven, S., & Olsen, C. K. (2016). Which cognitive domains are improved by treatment with vortioxetine. International Journal of Neuropsychopharmacology, 19(10), pyw054. doi:10.1093/ijnp/pyw054
  • Hasselbalch, B. J., Knorr, U., Hasselbalch, S. G., Gade, A., & Kessing, L. V. (2013). The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. European Psychiatry, 28(6), 349–355. doi:10.1016/j.eurpsy.2012.03.004
  • Herrera-Guzmán, I., Gudayol-Ferré, E., Lira-Mandujano, J., Herrera-Abarca, J., Herrera-Guzmán, D., Montoya-Pérez, K., & Guardia-Olmos, J. (2008). Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder. Psychiatry Research, 160(1), 72–82. doi:10.1016/j.psychres.2007.04.012
  • Herrmann, L. L., Goodwin, G. M., & Ebmeier, K. P. (2007). The cognitive neuropsychology of depression in the elderly. Psychological Medicine, 37(12), 1693–1702. doi:10.1017/S0033291707001134
  • Hickie, I., Ward, P., Scott, E., Haindl, W., Walker, B., Dixon, J., & Turner, K. (1999). Neo-striatal rCBF correlates of psychomotor slowing in patients with major depression. Psychiatry Research: Neuroimaging, 92(2–3), 75–81. doi:10.1016/S0925-4927(99)00038-4
  • Ho, S. C., Chong, H. Y., Chaiyakunapruk, N., Tangiisuran, B., & Jacob, S. A. (2016). Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review. Journal of Affective Disorders, 193, 1–10. doi:10.1016/j.jad.2015.12.029
  • Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006). Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research, 145(1), 39–48. doi:10.1016/j.psychres.2005.11.011
  • Jamaluddin, R., Othman, Z., Musa, K. I., & Muhammad Alwi, M. N. (2009). Validation of the Malay version of Auditory Verbal Learning Test (MVAVLT). Early online edition. ASEAN Journal of Psychiatry, 10, 54–74.
  • Ji, Y., Li, W., Liu, B., Liu, J., Ju, Y., Wang, M., Chen, Y., & Li, L. (2020). Clinical characteristics of cognitive deficits in major depressive disorder: A 6-month prospective study. Archives of Clinical Psychiatry, 47(4), 101–105. Aug 26doi:10.1590/0101-60830000000241
  • Jorm, A. F. (1986). Cognitive deficit in the depressed elderly: A review of some basic unresolved issues. The Australian and New Zealand Journal of Psychiatry, 20(1), 11–22. doi:10.3109/00048678609158860
  • Kallus, K. W., Schmitt, J. A., & Benton, D. (2005). Attention, psychomotor functions and age. European Journal of Nutrition, 44(8), 465–484. doi:10.1007/s00394-005-0584-5
  • Karnam, R. R., Kumar, N. S., Eshwar, S., & Deolia, S. (2016). Cognitive ability as a determinant of socioeconomic and oral health status among adolescent college students of Bengaluru, India. Journal of Clinical and Diagnostic Research, 10(12), ZC62–ZC66. doi:10.7860/JCDR/2016/21132.9102
  • Katon, W., Von Korff, M., Lin, E., & Simon, G. (2001). Rethinking practitioner roles in chronic illness: The specialist, primary care physician, and the practice nurse. General Hospital Psychiatry, 2001 23(3), 138–144. doi:10.1016/S0163-8343(01)00136-0
  • Kelly, C. M., Jorm, A. F., & Wright, A. (2007). Improving mental health literacy as a strategy to facilitate early intervention for mental disorders. The Medical Journal of Australia, 187(S7), S26–S30. doi:10.5694/j.1326-5377.2007.tb01332.x
  • Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., McInerney, S. J., McIntosh, D., Milev, R. V., Müller, D. J., Parikh, S. V., Pearson, N. L., Ravindran, A. V., & Uher, R. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 61(9), 540–560. doi:10.1177/0706743716659417
  • Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM–IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602. doi:10.1001/archpsyc.62.6.593
  • Klimkeit, E. I., Tonge, B., Bradshaw, J. L., Melvin, G. A., & Gould, K. (2011). Neuropsychological deficits in adolescent unipolar depression. Archives of Clinical Neuropsychology, 26(7), 662–676. doi:10.1093/arclin/acr051
  • Kline, R. B. (2011). Principles and practice of structural equation modelling (3rd ed.). The Guilford Press.
  • Kurtz, M. M., & Gerraty, R. T. (2009). A meta-analytic investigation of neurocognitive deficits in bipolar illness: Profile and effects of clinical state. Neuropsychology, 23(5), 551–562. doi:10.1037/a0016277
  • Lam, R. W., Kennedy, S. H., Mclntyre, R. S., & Khullar, A. (2014). Cognitive dysfunction in major depressive disorder: Effects on psychosocial functioning and implications for treatment. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 59(12), 649–654. doi:10.1177/070674371405901206
  • Lampe, I. K., Sitskoorn, M. M., & Heeren, T. J. (2004). Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients. Psychiatry Research, 125(2), 73–79. doi:10.1016/j.psychres.2003.12.004
  • Landrø, N. I., Stiles, T. C., & Sletvold, H. (2001). Neuropsychological function in nonpsychotic unipolar major depression. Cognitive and Behavioral Neurology, 14(4), 233–240.
  • Laws of Malaysia. (1971). Age of Majority Act. http://www.agc.gov.my/agcportal/uploads/files/Publications/LOM/EN/Act%2021.pdf
  • Lee, B. H., & Kim, Y. K. (2010). The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investigation, 7(4), 231–235. doi:10.4306/pi.2010.7.4.231
  • Lee, R. S., Hermens, D. F., Porter, M. A., & Redoblado-Hodge, M. A. (2012). A meta-analysis of cognitive deficits in first-episode major depressive disorder. Journal of Affective Disorders, 140(2), 113–124. doi:10.1016/j.jad.2011.10.023
  • Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological Assessment (4th ed.). Oxford University Press.
  • Listunova, L., Roth, C., Bartolovic, M., Kienzle, J., Bach, C., Weisbrod, M., & Roesch-Ely, D. (2018). Cognitive impairment along the course of depression: Non-pharmacological treatment options. Psychopathology, 51(5), 295–305. doi:10.1159/000492620
  • Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2015). A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology, 40(8), 2025–2037. doi:10.1038/npp.2015.52
  • Maj, M., D'Elia, L., Satz, P., Janssen, R., Zaudig, M., Uchiyama, C., Starace, F., Galderisi, S., & Chervinsky, A. (1993). Evaluation of two neuropsychological tests designed to minimize cultural bias in the assessment of HIV-I seropositive person: A WHO study. Archives of Clinical Neuropsychology, 8(2), 123–135. doi:10.1093/arclin/8.2.123
  • Marazziti, D., Consoli, G., Picchetti, M., Carlini, M., & Faravelli, L. (2010). Cognitive impairment in major depression. European Journal of Pharmacology, 626(1), 83–86. doi:10.1016/j.ejphar.2009.08.046
  • Marvel, C. L., & Paradiso, S. (2004). Cognitive and neurological impairment in mood disorders. Psychiatric Clinics of North America, 27(1), 19–36. vii–viii. doi:10.1016/S0193-953X(03)00106-0
  • Matthews, K., Coghill, D., & Rhodes, S. (2008). Neuropsychological functioning in depressed adolescent girls. Journal of Affective Disorders, 111(1), 113–118. doi:10.1016/j.jad.2008.02.003
  • Mattson, M. P. (2000). Neuroprotective signalling and the aging brain: Take away my food and let me run. Brain Research, 886(1–2), 47–53. doi:10.1016/S0006-8993(00)02790-6
  • McClintock, S. M., Husain, M. M., Greer, T. L., & Cullum, C. M. (2010). Association between depression severity and neurocognitive function in major depressive disorder. Neuropsychology, 24(1), 9–34. doi:10.1037/a0017336
  • McDermott, L. M., & Ebmeier, K. P. (2009). A meta-analysis of depression severity and cognitive function. Journal of Affective Disorders, 119(1–3), 1–8. doi:10.1016/j.jad.2009.04.022
  • McIntyre, R. S., & Cha, D. S. (2016). Cognitive impairment in major depressive disorder: Clinical relevance, biological substrates, and treatment opportunities. Cambridge University Press.
  • McIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013). Cognitive deficits and functional outcomes in major depressive disorder: Determinants, substrates, and treatment interventions. Depression and Anxiety, 30(6), 515–527. doi:10.1002/da.22063
  • McIntyre, R. S., Harrison, J., Loft, H., Jacobson, W., & Olsen, C. K. (2016). The effects of vortioxetine on cognitive function in patients with major depressive disorder: A meta-analysis of three randomized controlled trials. International Journal of Neuropsychopharmacology, 19(10), pyw055. doi:10.1093/ijnp/pyw055
  • McIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014). A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. The International Journal of Neuropsychopharmacology, 17(10), 1557–1567. doi:10.1017/S1461145714000546
  • McKinnon, M. C., Yucel, K., Nazarov, A., & MacQueen, G. M. (2009). A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. Journal of Psychiatry & Neuroscience, 34(1), 41–54.
  • Meyer, B., Bierbrodt, J., Schröder, J., Berger, T., Beevers, C. G., Weiss, M., Jacob, G., Späth, C., Andersson, G., Lutz, W., Hautzinger, M., Löwe, B., Rose, M., Hohagen, F., Caspar, F., Greiner, W., Moritz, S., & Klein, J. P. (2015). Effects of an Internet intervention (Deprexis) on severe depression symptoms: Randomized controlled trial. Internet Interventions., 2(1), 48–59. doi:10.1016/j.invent.2014.12.003
  • Millan, M. J. (2004). The role of monoamines in the actions of established and “novel” antidepressant agents: A critical review. European Journal of Pharmacology, 500(1-3), 371–384. doi:10.1016/j.ejphar.2004.07.038
  • Ministry of Health, Malaysia. (2019). National Health Morbidity Survey. Institute for Public Health.
  • Mirowsky, J., & Ross, C. E. (1998). Education, personal control, lifestyle and health: A human capital hypothesis. Research on Aging, 20(4), 415–449. doi:10.1177/0164027598204003
  • Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. The British Journal of Psychiatry, 134(4), 382–389. doi:10.1192/bjp.134.4.382
  • Mukhtar, F., & Oei, T. P. (2011). A review on assessment and treatment for depression in Malaysia. Depression Research and Treatment, 2011, 123642. doi:10.1155/2011/123642
  • Müller-Thomsen, T., Arlt, S., Mann, U., Mass, R., & Ganzer, S. (2005). Detecting depression in Alzheimer’s disease: Evaluation of four different scales. Archives of Clinical Neuropsychology, 20(2), 271–276. doi:10.1016/j.acn.2004.03.010
  • Munjir, N., Othman, Z., Zakaria, R., Shafin, N., Hussain, N. A., Desa, A. M., & Ahmad, A. H. (2015). Equivalence and practice effect of alternate forms for Malay version of Auditory Verbal Learning Test (MAVLT). EXCLI Journal, 14, 801–808.
  • Naismith, S. L., Hickie, I. B., Turner, K., Little, C. L., Winter, V., Ward, P. B., Wilhelm, K., Mitchell, P., & Parker, G. (2003). Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. Journal of Clinical and Experimental Neuropsychology, 25(6), 866–877. doi:10.1076/jcen.25.6.866.16472
  • Ng, C. G. (2014). A review of depression research in Malaysia. The Medical Journal of Malaysia, 69, 42–45.
  • Paelecke-Habermann, Y., Pohl, J., & Leplow, B. (2005). Attention and executive functions in remitted major depression patients. Journal of Affective Disorders, 89(1–3), 125–135. doi:10.1016/j.jad.2005.09.006
  • Pehrson, A. L., & Sanchez, C. (2014). Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectrums, 19(2), 121–133. doi:10.1017/S1092852913000540
  • Porter, R. J., Bourke, C., & Gallagher, P. (2007). Neuropsychological impairment in major depression: Its nature, origin and clinical significance. The Australian and New Zealand Journal of Psychiatry, 41(2), 115–128. doi:10.1080/00048670601109881
  • Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003). Neurocognitive impairment in drug-free patients with major depressive disorder. The British Journal of Psychiatry, 182(3), 214–220. doi:10.1192/bjp.182.3.214
  • Preiss, M., Kucerova, H., Lukavsky, J., Stepankova, H., Sos, P., & Kawaciukova, R. (2009). Cognitive deficits in the euthymic phase of unipolar depression. Psychiatry Research, 169(3), 235–239. doi:10.1016/j.psychres.2008.06.042
  • Priyamvada, R., Ranjan, R., & Chaudhury, S. (2015). Cognitive rehabilitation of attention and memory in depression. Industrial Psychiatry Journal, 24(1), 48–53. doi:10.4103/0972-6748.160932
  • Ravnkilde, B., Videbech, P., Clemmensen, K., Egander, A., Rasmussen, N. A., & Rosenberg, R. (2002). Cognitive deficits in major depression. Scandinavian Journal of Psychology, 43(3), 239–251. doi:10.1111/1467-9450.00292
  • Reitan, R. M. (1992). Trail Making Test. Reitan Neuropsychology Laboratory.
  • Rey, A. (1941). L'examen psychologique dans les cas d‘encéphalopathie traumatique. (Les problems.) [The psychological examination in cases of traumatic encepholopathy. Problems.]. Archives de Psychologie, 28, 215–285.
  • Riso, L. P., Miyatake, R. K., & Thase, M. E. (2002). The search for determinants of chronic depression: A review of six factors. Journal of Affective Disorders, 70(2), 103–115. doi:10.1016/S0165-0327(01)00376-7
  • Roiser, J. P., & Sahakian, B. J. (2013). Hot and cold cognition in depression. CNS Spectrums, 18(3), 139–149. doi:10.1017/S1092852913000072
  • Ruhe, H. G., Mocking, R. J. T., Figueroa, C. A., Seeverens, P. W. J., Ikani, N., Tyborowska, A., Browning, M., Vrijsen, J. N., Harmer, C. J., & Schene, A. H. (2019). Emotional biases and recurrence in Major Depressive Disorder. Results of 2.5 years follow-up of drug-free cohort vulnerable for recurrence. Frontiers in Psychiatry, 10, 145. doi:10.3389/fpsyt.2019.00145
  • Schwert, C., Aschenbrenner, S., Weisbrod, M., & Schröder, A. (2017). Cognitive impairments in unipolar depression: The impact of rumination. Psychopathology, 50(5), 347–354. doi:10.1159/000478785
  • Sheehan, D., Lecrubier, Y., Sheehan, K., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22–33.
  • Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996). Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America, 93(9), 3908–3913. doi:10.1073/pnas.93.9.3908
  • Snyder, H. R. (2013). Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review. Psychological Bulletin, 139(1), 81–132. doi:10.1037/a0028727.
  • Soares, J. C., & Mann, J. J. (1997). The functional neuroanatomy of mood disorders. Journal of Psychiatric Research, 31(4), 393–432. doi:10.1016/S0022-3956(97)00016-2
  • Steele, L. S., Dewa, C. S., Lin, E., & Lee, K. L. (2007). Education level, income level and mental health services use in Canada: Associations and policy implications. Healthcare Policy = Politiques de Sante, 3(1), 96–106. doi:10.12927/hcpol.2007.19177
  • Tham, A., Engelbrektson, K., Mathe, A. A., Johnson, L., Olsson, E. A., & Aberg-Wistedt, A. (1997). Impaired neuropsychological performance in euthymic patients with recurring mood disorders. The Journal of Clinical Psychiatry, 58(1), 26–29. doi:10.4088/JCP.v58n0105
  • Thomas, A. J., Gallagher, P., Robinson, L. J., Porter, R. J., Young, A. H., Ferrier, I. N., & O'Brien, J. T. (2009). A comparison of neurocognitive impairment in younger and older adults with major depression. Psychological Medicine, 39(5), 725–733. doi:10.1017/S0033291708004042
  • Thota, A. B., Sipe, T. A., Byard, G. J., Zometa, C. S., Hahn, R. A., McKnight-Eily, L. R., Chapman, D. P., Abraido-Lanza, A. F., Pearson, J. L., Anderson, C. W., Gelenberg, A. J., Hennessy, K. D., Duffy, F. F., Vernon-Smiley, M. E., Nease, D. E., & Williams, S. P. (2012). Collaborative care to improve the management of depressive disorders: A community guide systematic review and meta-analysis. American Journal of Preventive Medicine, 42(5), 525–538. doi:10.1016/j.amepre.2012.01.019
  • Trivedi, M. H., & Greer, T. L. (2014). Cognitive dysfunction in unipolar depression: Implications for treatment. Journal of Affective Disorders, 152–154, 19–27. doi:10.1016/j.jad.2013.09.012
  • Urbaniak, G. C., Plous, S. (2015). Research Randomizer (Version 4.0) [Computer Software]. http://www.randomizer.org
  • Ustun, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004). Global burden of depressive disorders in the year 2000. The British Journal of Psychiatry, 184, 386–392. doi:10.1192/bjp.184.5.386
  • Vance, D. E., Webb, N. M., Marceaux, J. C., Viamonte, S. M., Foote, A. W., & Ball, K. K. (2008). Mental stimulation, neural plasticity, and aging: Directions for nursing research and practice. The Journal of Neuroscience Nursing, 40(4), 241–249. doi:10.1097/01376517-200808000-00008
  • Wagner, E. H. (1998). Chronic disease management: What will it take to improve care for chronic illness? Effective Clinical Practice, 1(1), 2–4.
  • Wagner, S., Doering, B., Helmreich, I., Lieb, K., & Tadić, A. A. (2012). Meta‐analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Acta Psychiatrica Scandinavica, 125(4), 281–292. doi:10.1111/j.1600-0447.2011.01762.x
  • Wechsler, D. (1939). The measurement and appraisal of adult intelligence (1st ed.). Williams and Wilkins Corporation.
  • Wechsler, D. (1997). Wechsler Adult Intelligence Scale (3rd ed.). Texas, Psychological Corporation.
  • Wekking, E. M., Bockting, C. L., Koeter, M. W., & Schene, A. H. (2012). Cognitive functioning in euthymic recurrently depressed patients: Relationship with future relapses and prior course of disease. Journal of Affective Disorders, 141(2–3), 300–307. doi:10.1016/j.jad.2012.03.034
  • Williams, R. A., Hagerty, B. M., Cimprich, B., Therrien, B., Bay, E., & Oe, H. (2000). Changes in directed attention and short-term memory in depression. Journal of Psychiatric Research, 34(3), 227–238. doi:10.1016/S0022-3956(00)00012-1
  • Withal, A., Harris, L. M., & Cumming, S. R. (2010). A longitudinal study of cognitive function in melancholic and non-melancholic subtypes of major depressive disorder. Journal of Affective Disorders, 123(1–3), 150–157. doi:10.1016/j.jad.2009.07.012
  • Woo, Y. S., Rosenblat, J. D., Kakar, R., Bahk, W. M., & McIntyre, R. S. (2016). Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clinical Psychopharmacology and Neuroscience, 14(1), 1–16. doi:10.9758/cpn.2016.14.1.1
  • World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research (Vol. 2). World Health Organization.
  • World Health Organization. (2004). Promoting mental health: Concepts, emerging evidence, practice: A report of the World Health Organization, Department of Mental Health and Substance Abuse in collaboration with the Victorian Health Promotion Foundation and the University of Melbourne. http://apps.who.int/iris/bitstream/10665/42940/1/9241591595.pdf
  • World Health Organization. (2010). Definition of an older or elderly person. WHO. http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.html
  • Zisook, S., Lesser, I., Stewart, J. W., Wisniewski, S. R., Balasubramani, G. K., Fava, M., Gilmer, W. S., Dresselhaus, T. R., Thase, M. E., Nierenberg, A. A., Trivedi, M. H., & Rush, A. J. (2007). Effect of age at onset on the course of major depressive disorder. The American Journal of Psychiatry, 164(10), 1539–1546. doi:10.1176/appi.ajp.2007.06101757

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.